These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26103611)

  • 1. Importance of early recognition of heterozygous familial hypercholesterolaemia.
    Ryan A; Byrne CD
    Curr Opin Lipidol; 2015 Aug; 26(4):298-303. PubMed ID: 26103611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of people with heterozygous familial hypercholesterolemia.
    Haase A; Goldberg AC
    Curr Opin Lipidol; 2012 Aug; 23(4):282-9. PubMed ID: 22801386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial hypercholesterolaemia.
    Nair DR; Sharifi M; Al-Rasadi K
    Curr Opin Cardiol; 2014 Jul; 29(4):381-8. PubMed ID: 24870549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe familial hypercholesterolaemia: current and future management.
    Farnier M; Bruckert E
    Arch Cardiovasc Dis; 2012 Dec; 105(12):656-65. PubMed ID: 23199621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study.
    European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration
    Lancet; 2024 Jan; 403(10421):55-66. PubMed ID: 38101429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of familial heterozygous hypercholesterolaemia. Position paper of the Polish Lipid Expert Forum].
    Rynkiewicz A; Cybulska B; Banach M; Filipiak KJ; Guzik T; Idzior Waluś B; Imiela J; Jankowski P; Kłosiewicz Latoszek L; Limon J; Myśliwiec M; Opolski G; Steciwko A; Stępińska J; Zdrojewski T;
    Kardiol Pol; 2013; 71(1):107-11. PubMed ID: 23348551
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for familial hypercholesterolaemia.
    Bender R; Bell DA; Hooper AJ; Edwards G; van Bockxmeer FM; Watts GF; Burnett JR
    Pathology; 2012 Feb; 44(2):122-8. PubMed ID: 22228254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hinterland of familial hypercholesterolaemia: what do we not know?
    Wierzbicki AS; Watts GF
    Curr Opin Lipidol; 2015 Dec; 26(6):475-83. PubMed ID: 26780001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.
    Bell DA; Pang J; Burrows S; Bates TR; van Bockxmeer FM; Hooper AJ; O'Leary P; Burnett JR; Watts GF
    Atherosclerosis; 2015 Mar; 239(1):93-100. PubMed ID: 25585028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands.
    Umans-Eckenhausen MA; Defesche JC; Sijbrands EJ; Scheerder RL; Kastelein JJ
    Lancet; 2001 Jan; 357(9251):165-8. PubMed ID: 11213091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygous familial hypercholesterolaemia in childhood: cardiovascular risk prevention.
    van der Graaf A; Kastelein JJP; Wiegman A
    J Inherit Metab Dis; 2009 Dec; 32(6):699. PubMed ID: 19898954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial hypercholesterolaemia: a pressing issue for European health care.
    Brice P; Burton H; Edwards CW; Humphries SE; Aitman TJ
    Atherosclerosis; 2013 Dec; 231(2):223-6. PubMed ID: 24267231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of European and US guidelines for familial hypercholesterolaemia.
    Reiner Ž
    Curr Opin Lipidol; 2015 Jun; 26(3):215-20. PubMed ID: 25943839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of child-parent screening and cascade testing for familial hypercholesterolaemia.
    Wald DS; Wald NJ
    J Med Screen; 2019 Jun; 26(2):71-75. PubMed ID: 30319009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the cost-effectiveness equation of cascade testing for familial hypercholesterolaemia.
    Pears R; Griffin M; Futema M; Humphries SE
    Curr Opin Lipidol; 2015 Jun; 26(3):162-8. PubMed ID: 25887683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmes.
    Marks D; Thorogood M; Neil SM; Humphries SE; Neil HA
    J Med Screen; 2006; 13(3):156-9. PubMed ID: 17007658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial hypercholesterolemia in children and adolescents.
    McCrindle BW
    Curr Opin Lipidol; 2012 Dec; 23(6):525-31. PubMed ID: 22914663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study.
    Kastelein JJ; Besseling J; Shah S; Bergeron J; Langslet G; Hovingh GK; Al-Saady N; Koeijvoets M; Hunter J; Johnson-Levonas AO; Fable J; Sapre A; Mitchel Y
    Lancet; 2015 May; 385(9983):2153-61. PubMed ID: 25743173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond cascade screening: detection of familial hypercholesterolaemia at childhood immunization and other strategies.
    Martin AC; Bell DA; Brett T; Watts GF
    Curr Opin Lipidol; 2017 Aug; 28(4):321-327. PubMed ID: 28426524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.